Resumen

BONET PLA, A. et al. Cardiovascular risk factors control in diabetic patients visited in two Primary Health Care teams and associated direct costs. Part II: Direct cost analysis. Medifam [online]. 2002, vol.12, n.8, pp.53-59. ISSN 1131-5768.

Background: diabetes care is responsible for almost 5% of health budget. Studies of cost and outcome altogether are scarce, mainly in Spain. Aim: to study management of type 2 diabetes in Primary Health Care, taking into account health care outcomes upon 1998 European Consensus criteria and direct costs imputed. Patiens and methods: we studied 513 patients from two urban health care centers visited in 1997. We colected descriptive independent variables and as dependent variable control degree upon 1998 European Consensus criteria. As directs costs we assessed professional care (doctors and nurses time), laboratory test and medications. We present mean patient cost and the mean and total costs of the different control level. Results: total cost is 15.262.668 pesetas. 77.6% of cost is due to prescribed drugs, 14.3% to laboratory test and 8.1% to personnel cost. Total mean cost is 29.751 pesetas. Well controled mean cost is 77.475 pesetas. Cost of patient that reach low risk considering the whole CVRF is 1.695.852 pesetas. Conclusions: the wide range of cost is a consequence of the unefficience in the management of diabetes. Our results show how wrong the strategy of means costs is. Opposite to it, dividing only cost among those patients well controled enhances unefficiency.

Palabras clave : Diabetes; Cardiovascular risk factors; Outcome assessment.

        · resumen en Español     · texto en Español     · Español ( pdf )